Search by Drug Name or NDC
NDC 00074-1070-02 Skyrizi Details
Skyrizi
Skyrizi is a INTRAVENOUS KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AbbVie Inc.. The primary component is .
Product Information
NDC | 00074-1070 |
---|---|
Product ID | 0074-1070_7718dd85-622c-478e-ae9b-91e14a1373c6 |
Associated GPIs | |
GCN Sequence Number | 083492 |
GCN Sequence Number Description | risankizumab-rzaa WEAR INJCT 360 MG/2.4 SUBCUT |
HIC3 | V4E |
HIC3 Description | IL-23 RECEPTOR ANTAGONIST, MONOCLONAL ANTIBODY |
GCN | 52475 |
HICL Sequence Number | 045699 |
HICL Sequence Number Description | RISANKIZUMAB-RZAA |
Brand/Generic | Brand |
Proprietary Name | Skyrizi |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Risankizumab-rzaa |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | KIT |
Route | INTRAVENOUS |
Active Ingredient Strength | n/a |
Active Ingredient Units | n/a |
Substance Name | n/a |
Labeler Name | AbbVie Inc. |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | BLA |
Application Number | BLA761105 |
Listing Certified Through | 2025-12-31 |
Package
NDC 00074-1070-02 (00074107002)
NDC Package Code | 0074-1070-02 |
---|---|
Billing NDC | 00074107002 |
Package | 1 KIT in 1 CARTON (0074-1070-02) * 2.4 mL in 1 CARTRIDGE (0074-1069-02) * 2.4 mL in 1 CARTRIDGE (0074-1069-01) |
Marketing Start Date | 2022-06-16 |
NDC Exclude Flag | N |
Pricing Information | N/A |